Multiple Cases of Facial Disfigurement From Filler Use and One Injector.
Autor: | Parikh AO; USC Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, California., Conger JR; USC Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, California.; Eyesthetica, Los Angeles, California., Sibug Saber ME; USC Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, California.; Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California, U.S.A., Samimi D; USC Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, California.; Eyesthetica, Los Angeles, California., Burnstine MA; USC Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, California.; Eyesthetica, Los Angeles, California. |
---|---|
Jazyk: | angličtina |
Zdroj: | Ophthalmic plastic and reconstructive surgery [Ophthalmic Plast Reconstr Surg] 2023 Jul-Aug 01; Vol. 39 (4), pp. 366-369. Date of Electronic Publication: 2023 Feb 02. |
DOI: | 10.1097/IOP.0000000000002323 |
Abstrakt: | Purpose: To present a case of facial disfigurement from an injectable permanent filler and describe the consequences to patients exposed to the same injector (common source outbreak). Methods: Case report and discussion of a common source outbreak after a group of persons developed complications years after permanent filler given by one injector. Results: A 39-year-old transgender model underwent polymethylmethacrylate (Artefill) facial filler injections to the lips, cheeks, and chin in 2018. A year later, the patient presented to the emergency room with severe facial swelling and difficulty breathing. Treatments have included 4 surgeries to remove filler and scar tissue and chronic low-dose oral steroid therapy. Upon questioning the patient, 6 additional people suffered from similar facial swelling years after injection by the same injector. The injector cannot be located. Conclusions: Care must be taken in giving all facial fillers, particularly permanent ones. When one source patient is identified, questioning the patient's knowledge of others affected is critical to help manage an epidemic problem and to report a rogue injector. Physicians have a duty to investigate and report such cases. Competing Interests: The authors have no financial or conflicts of interest to disclose. (Copyright © 2023 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |